Loading the security overview…
Where the tokens are
| Quarter | Reported | EPS | EPS vs year ago | Revenue | Revenue vs year ago | Consensus EPS |
|---|---|---|---|---|---|---|
| Q1 FY27ended Jul 31, 2026 | Sep 1, 2026 | $1.14 | +40.7% | $9.76B | +13.7% | $1.39 |
| Q4 FY26ended Apr 24, 2026 | Jun 3, 2026 | $0.97 | +18.3% | $9.81B | +9.9% | $1.54 |
| Q3 FY26ended Jan 23, 2026 | — | $0.89 | −11.9% | $9.02B | +8.7% | — |
| Q2 FY26ended Oct 24, 2025 | — | $1.07 | +8.1% | $8.96B | +6.6% | — |
| Q1 FY26ended Jul 25, 2025 | — | $0.81 | +1.3% | $8.58B | +8.4% | — |
| Q4 FY25ended Apr 25, 2025 | — | $0.82 | +67.3% | $8.93B | +3.9% | — |
| Q3 FY25ended Jan 24, 2025 | — | $1.01 | +2.0% | $8.29B | +2.5% | — |
| Q2 FY25ended Oct 25, 2024 | — | $0.99 | +45.6% | $8.40B | +5.2% |
Growth compares each quarter with the same fiscal quarter a year earlier, and is left blank where that quarter is missing or its figure was zero or a loss. Consensus is the estimate published before each report. It usually refers to adjusted EPS, so it is shown beside the GAAP figure rather than subtracted from it: the difference would not be a beat or a miss.
Figures describe Medtronic shares, not any token. As of Sep 1, 2026, from Massive's standardised financials and the earnings calendar.
| — |
| Q1 FY25ended Jul 26, 2024 | — | $0.80 | — | $7.92B | — | — |
| Q4 FY24ended Apr 26, 2024 | — | $0.49 | — | $8.59B | — | — |
| Q3 FY24ended Jan 26, 2024 | — | $0.99 | — | $8.09B | — | — |
| Q2 FY24ended Oct 27, 2023 | — | $0.68 | — | $7.98B | — | — |